Presentations at Congresses

Intravitreal Pegcetacoplan


To learn more about Apellis clinical trials go to
Please refer to the U.S. Prescribing Information for EMPAVELI.

The safety and efficacy of the agents for the indications under investigation have not been established. There is no guarantee that the outcome of these studies will result in approval by a Health Authority.

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

You are now leaving

You are about to leave to visit a third-party website. We recommend reviewing the privacy policy and terms & conditions of any site you visit, as Apellis Pharmaceuticals, Inc. is not responsible for their content.